These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31522319)

  • 1. Clinico-genetic model to predict methotrexate intolerance in rheumatoid arthritis.
    Sandhu A; Dhir V; Ahmad S; Dhawan V; Kaur J; Bhatnagar A
    Clin Rheumatol; 2020 Jan; 39(1):201-206. PubMed ID: 31522319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
    Sandhu A; Ahmad S; Kaur J; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2018 Dec; 37(12):3221-3228. PubMed ID: 30022368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients.
    Muralidharan N; Sundaram R; Kodidela S; Chengappa KG; Mariaselvam CM; Misra DP; Negi VS
    Pharmacogenomics J; 2020 Apr; 20(2):342-349. PubMed ID: 31611592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
    van der Straaten RJ; Wessels JA; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Allaart CF; Bogaartz J; Tiller M; Huizinga TW; Guchelaar HJ
    Pharmacogenomics; 2007 Feb; 8(2):141-50. PubMed ID: 17286537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
    Fatimah N; Salim B; Nasim A; Hussain K; Gul H; Niazi S
    Clin Rheumatol; 2016 May; 35(5):1341-5. PubMed ID: 27053094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
    Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
    Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
    Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
    Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
    Davis LA; Polk B; Mann A; Wolff RK; Kerr GS; Reimold AM; Cannon GW; Mikuls TR; Caplan L
    Clin Exp Rheumatol; 2014; 32(3):324-32. PubMed ID: 24447348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.
    Chen Y; Zou K; Sun J; Yang Y; Liu G
    Pharmacogenomics; 2017 Jan; 18(2):175-195. PubMed ID: 27992285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS).
    Amaral JM; Brito MJM; Kakehasi AM
    Adv Rheumatol; 2020 Aug; 60(1):43. PubMed ID: 32843102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis.
    Dalkilic E; Sahbazlar M; Gullulu M; Yavuz M; Dilek K; Ersoy A; Ozkaya G; Yurtkuran M
    Mod Rheumatol; 2013 May; 23(3):525-8. PubMed ID: 22752502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing methotrexate intolerance and its prevalence in rheumatoid arthritis: Development and validation of the MISA questionnaire.
    Vijaykumar D; Dhir V; Jain S; Pai V; Kaur J; Naidu GS; Sharma A; Khanna Sharma S; Jain S
    Int J Rheum Dis; 2021 Oct; 24(10):1294-1301. PubMed ID: 34432365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
    Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
    Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis.
    Saif S; Kakalia S; Kitchlew R; Khan HA; Fida S; Siddique M
    J Coll Physicians Surg Pak; 2022 Oct; 32(10):1308-1312. PubMed ID: 36205276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.
    Kooloos WM; Wessels JA; van der Straaten T; Allaart CF; Huizinga TW; Guchelaar HJ
    Pharmacogenomics; 2010 Feb; 11(2):163-75. PubMed ID: 20136356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Events Profile of Low-dose Methotrexate in Nepalese Patients with Rheumatoid Arthritis: an Observational Study.
    Nakarmi S; Pudasaini K; Adhikari B; Vaidya B
    J Nepal Health Res Counc; 2020 Nov; 18(3):360-365. PubMed ID: 33210624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
    Muralidharan N; Mariaselvam CM; Mithun CB; Negi VS
    Clin Rheumatol; 2016 Apr; 35(4):879-85. PubMed ID: 25771854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
    Pavelka K; Akkoç N; Al-Maini M; Zerbini CAF; Karateev DE; Nasonov EL; Rahman MU; Pedersen R; Dinh A; Shen Q; Vasilescu R; Kotak S; Mahgoub E; Vlahos B
    Rheumatol Int; 2017 Sep; 37(9):1469-1479. PubMed ID: 28597306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.